May 16 2025 Willful Enough: How Halozyme Is Putting Merck on Notice By: Erin Daly By: Erin Daly May 16, 2025 General In the ongoing litigation between Halozyme, Inc. and Merck Sharp & Dohme Corp., the issue of willful patent infringement takes... General Read More
Feb 28 2025 Navigating AI Patent Protection: Strategic Considerations for Biotech Companies By: Brent Nix By: Brent Nix February 28, 2025 General As artificial intelligence (AI) continues transforming the biotechnology landscape, protecting AI-related innovations has become... General Read More
Dec 13 2024 Branching Misunderstandings: When Chemistry Meets Legalese in Alnylam v. Moderna By: Erin Daly By: Erin Daly December 13, 2024 Patents The clash between these two companies spotlights a fascinating intersection of chemical innovation and patent law and serves as a reminder... Patents Read More
Sep 24 2024 Patent Eligibility of Diagnostic Gene Signature Method Claims By: Christopher Southgate By: Christopher Southgate September 24, 2024 Insights A claim drafting strategy assuring the patent subject matter eligibility of diagnostic gene signature method claims is discussed in light... Insights Read More
Sep 10 2024 Leveraging Patent Term Adjustment Strategies to Add Value to Your Company’s Patent Portfolio By: John Sears By: John Sears September 10, 2024 Patents A single day of additional patent protection can mean millions of dollars in revenue. This is where effective strategies to maximize Patent... Patents Read More